website-logo (2).png
Cancer Vaccine Market Anticipates 11.8% CAGR Fueled by Government Funding and Research Initiatives - Marketresearch.biz Study
October 23, 2023 06:50 ET | MarketResearch.biz
New York, Oct. 23, 2023 (GLOBE NEWSWIRE) -- The cancer vaccine market is expected to witness growth with an estimated increase from US$ 6.8 Billion in 2022 to around US$ 20.2 Billion by the year...
logo.png
Cancer Vaccine Market Size to Surpass Around USD 26.89 Billion by 2032
September 18, 2023 14:09 ET | Precedence Research
Ottawa, Sept. 18, 2023 (GLOBE NEWSWIRE) -- According to Precedence Research, the global cancer vaccine market size was valued at USD 9.12 billion in 2022. A vaccine developed for vaccine is type of...
Zion Market Research.jpg
[Latest] Global Cancer Vaccine Market Size Envisioned at USD 18.03 Billion by 2030, Increasing a CAGR of 11.6% | Healthcare Revolution
September 11, 2023 07:42 ET | Zion Market Research
NEW YORK, United States, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Cancer Vaccine Market By Type (Preventive Cancer Vaccines, And...
logo.jpg
Neoantigens Personalized Cancer Vaccine Clinical Trials Insight
July 05, 2022 07:22 ET | KuicK Research
Delhi, July 05, 2022 (GLOBE NEWSWIRE) -- Global Personalized Cancer Vaccine Market Outlook 2028 Report Highlights: Developmental Cost Analysis of a Personalized Cancer VaccineBiomarkers...
Vantage Market Research.png
Peptide Cancer Vaccine Market to Reach USD 10.07 Billion by 2028 - Vast Usage of Peptide Vaccine to Control Tumour Growth Propels the Market Demand – Vantage Market Research
February 15, 2022 03:33 ET | Vantage Market Research
WASHINGTON, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s recent analysis of the Global Peptide Cancer Vaccine Market finds that Peptide Cancer Vaccine aids to provide tumour-specific...